The role ofBRAFmutations in primary melanoma growth rate and survival

More People Die from Thin Melanomas (≤1 mm) than from Thick Melanomas (>4 mm) in Queensland, Australia

(2015) David C. Whiteman et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

An objective measure of growth rate using partial biopsy specimens of melanomas that were initially misdiagnosed

(2014) Matthew J. Lin et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Prognostic value of BRAF mutations in localized cutaneous melanoma

(2014) Eduardo Nagore et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Clinical and pathological associations of the activatingRAC1P29S mutation in primary cutaneous melanoma

(2014) Victoria J. Mar et al.   Pigment Cell & Melanoma Research

The clinical significance ofBRAFandNRASmutations in a clinic-based metastatic melanoma cohort

(2013) H. Ekedahl et al.   BRITISH JOURNAL OF DERMATOLOGY

Clinical characteristics and outcomes with specificBRAFandNRASmutations in patients with metastatic melanoma

(2013) Amanda D. Bucheit et al.   CANCER

Prevalence of BRAF and NRAS mutations in fast-growing melanomas

(2013) Eduardo Nagore et al.   Pigment Cell & Melanoma Research

A multisite blinded study for the detection of BRAF mutations in formalin-fixed, paraffin-embedded malignant melanoma

(2013) Anna Richter et al.   Scientific Reports

Prognostic Value of BRAF V600 Mutations in Melanoma Patients After Resection of Metastatic Lymph Nodes

(2012) Stéphanie Moreau et al.   ANNALS OF SURGICAL ONCOLOGY

Prediction of Sentinel Lymph Node Positivity by Growth Rate of Cutaneous Melanoma

(2012) Antonio Tejera-Vaquerizo et al.   ARCHIVES OF DERMATOLOGY

Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma

(2012) A. M. Menzies et al.   CLINICAL CANCER RESEARCH

BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma

(2012) Graham J. Mann et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Prevalence of BRAF V600E mutation in Chinese melanoma patients: Large scale analysis of BRAF and NRAS mutations in a 432-case cohort

(2011) Lu Si et al.   EUROPEAN JOURNAL OF CANCER

Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database

(2011) John F. Thompson et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic and Clinicopathologic Associations of OncogenicBRAFin Metastatic Melanoma

(2011) Georgina V. Long et al.   JOURNAL OF CLINICAL ONCOLOGY

Growth rate as an independent prognostic factor in localized invasive cutaneous melanoma

(2011) E Nagore et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma

(2011) Bianca Devitt et al.   Pigment Cell & Melanoma Research

Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma

(2010) J. A. Ellerhorst et al.   CLINICAL CANCER RESEARCH

Correlation of the growth rate of melanoma with the temporal appearance of metastasis

(2010) A Tejera-Vaquerizo et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Defining fast-growing melanomas

(2010) Antonio Martorell-Calatayud et al.   MELANOMA RESEARCH

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

Growth rate as a prognostic factor in localized invasive cutaneous melanoma

(2009) A Tejera-Vaquerizo et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Correlation of Subjective Self-reported Melanoma Growth Rate With Objective Tumor Proliferation Markers

(2008) Wenyuan Liu et al.   ARCHIVES OF DERMATOLOGY